Kalypsys has a total of 342 patents globally, out of which 63 have been granted. Of these 342 patents, more than 14% patents are active. The USA is where Kalypsys has filed the maximum number of patents, followed by Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Kalypsys and is also the origin country of the firm.
Kalypsys was founded in the year 2001 by Kevin Lustig, Peter Schultz, Pratik Shah and Randall King. Company operates as a pharmaceutical company. The Company offers treatment for cardiovascular, metabolic, pain, inflammation, and oncology diseases.
Do read about some of the most popular patents of Kalypsys which have been covered by us in this article and also you can find Kalypsys patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kalypsys patent portfolio.
How many patents does Kalypsys have?
Kalypsys has a total of 342 patents globally. These patents belong to 88 unique patent families. Out of 342 patents, 49 patents are active.
How Many Patents did Kalypsys File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
Kalypsys Applications Filed
Kalypsys Patents Granted
2022
–
–
2021
–
1
2020
–
–
2019
–
–
2018
–
8
2017
–
1
2016
–
4
2015
–
4
2014
–
8
2013
3
6
2012
13
8
2011
32
7
How many Kalypsys patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kalypsys File in Different Countries?
Countries in which Kalypsys Filed Patents
Country
Patents
United States Of America
66
Europe
19
Canada
17
Taiwan
17
Argentina
15
Australia
14
Japan
14
China
13
Korea (South)
13
India
12
Mexico
11
Brazil
10
Israel
6
Uruguay
6
South Africa
5
Germany
4
Austria
4
Spain
4
Hong Kong (S.A.R.)
4
Philippines
3
New Zealand
3
Denmark
2
Hungary
2
Russia
1
Colombia
1
Singapore
1
Chile
1
Indonesia
1
Where are Research Centres of Kalypsys Patents Located?
10 Best Kalypsys Patents
US20080021026A1 is the most popular patent in the Kalypsys portfolio. It has received 175 citations so far from companies like Aerie Pharmaceuticals.Below is the list of 10 most cited patents of Kalypsys:
The chart below distributes patents filed by Kalypsysin different countries on the basis of the technology protected in patents. It also represents the markets where Kalypsys thinks it’s important to protect particular technology inventions.
R&D Focus: How has Kalypsys search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Kalypsys?
Avangrid has a total of 7 patents globally, with 6 granted and 3 currently active—representing over 42% of its portfolio. United States of America is where Avangrid has filed the…
Anthropics Technology has a total of 36 patents globally, out of which 11 have been granted. Of these 36 patents, 22% patents are active. United Kingdom is where Anthropics Technology…
Havells has a total of 1225 patents globally, out of which 1147 have been granted. Of these 1225 patents, more than 98% patents are active. India is where Havells has…
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Countries in which Kalypsys Filed Patents
